EE307 Budget Impact Analysis of Upadacitinib for Moderate-to-Severe Atopic Dermatitis for Social Security and Private Third-Party Payers in Argentina
Abstract
Authors
D. Kanevsky N. Espinola F. Rodriguez Cairoli C. Rojas-Roque P. Luna V. Migliazza D.A. Pichon-Riviere